Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 14 studies | 23% ± 8% | |
| lung | 12 studies | 31% ± 15% | |
| eye | 9 studies | 26% ± 10% | |
| brain | 8 studies | 34% ± 16% | |
| kidney | 7 studies | 22% ± 5% | |
| intestine | 6 studies | 31% ± 13% | |
| liver | 5 studies | 32% ± 24% | |
| lymph node | 5 studies | 26% ± 11% | |
| placenta | 4 studies | 27% ± 10% | |
| bone marrow | 4 studies | 20% ± 4% | |
| uterus | 4 studies | 29% ± 15% | |
| breast | 4 studies | 23% ± 3% | |
| pancreas | 3 studies | 43% ± 2% | |
| thymus | 3 studies | 40% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 3213.89 | 459 / 459 | 100% | 27.03 | 1118 / 1118 |
| esophagus | 100% | 3421.81 | 1445 / 1445 | 100% | 14.45 | 183 / 183 |
| ovary | 100% | 3556.17 | 180 / 180 | 100% | 20.01 | 430 / 430 |
| pancreas | 100% | 2706.93 | 328 / 328 | 100% | 15.33 | 178 / 178 |
| prostate | 100% | 3042.43 | 245 / 245 | 100% | 23.66 | 502 / 502 |
| thymus | 100% | 8589.07 | 653 / 653 | 100% | 47.56 | 605 / 605 |
| uterus | 100% | 3438.30 | 170 / 170 | 100% | 22.84 | 459 / 459 |
| brain | 100% | 4357.07 | 2641 / 2642 | 100% | 28.43 | 705 / 705 |
| liver | 100% | 2510.71 | 226 / 226 | 100% | 17.14 | 405 / 406 |
| kidney | 100% | 2992.44 | 89 / 89 | 100% | 18.93 | 898 / 901 |
| bladder | 100% | 3749.62 | 21 / 21 | 100% | 19.93 | 502 / 504 |
| adrenal gland | 100% | 4343.16 | 258 / 258 | 100% | 22.15 | 229 / 230 |
| lung | 99% | 2796.42 | 575 / 578 | 100% | 20.01 | 1155 / 1155 |
| stomach | 100% | 3054.11 | 359 / 359 | 99% | 16.59 | 283 / 286 |
| intestine | 100% | 3438.75 | 966 / 966 | 98% | 16.87 | 519 / 527 |
| skin | 100% | 3232.96 | 1807 / 1809 | 98% | 18.73 | 463 / 472 |
| adipose | 100% | 3308.06 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 27.09 | 29 / 29 |
| muscle | 100% | 6224.65 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2557.61 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 21.65 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.55 | 1 / 1 |
| blood vessel | 100% | 3445.46 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 97% | 3179.05 | 832 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 96% | 15.25 | 77 / 80 |
| peripheral blood | 93% | 2449.35 | 864 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000502 | Cellular component | proteasome complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0015036 | Molecular function | disulfide oxidoreductase activity |
| GO_0015035 | Molecular function | protein-disulfide reductase activity |
| Gene name | TXNL1 |
| Protein name | Epididymis secretory protein Li 114 (Thioredoxin-like 1, isoform CRA_c) Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein) Thioredoxin like 1 |
| Synonyms | TXL TRP32 hCG_23140 HEL-S-114 TXNL |
| Description | FUNCTION: Active thioredoxin with a redox potential of about -250 mV. . |
| Accessions | K7EPB7 O43396 ENST00000589329.5 ENST00000217515.11 ENST00000587613.1 K7ER96 K7EML9 ENST00000587807.5 K7EKG2 ENST00000590954.5 V9HW51 ENST00000586262.5 ENST00000589931.1 K7EME7 |